Home Cart Sign in  
Chemical Structure| 15965-57-8 Chemical Structure| 15965-57-8

Structure of 15965-57-8

Chemical Structure| 15965-57-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 15965-57-8 ]

CAS No. :15965-57-8
Formula : C8H7ClN2
M.W : 166.61
SMILES Code : CC1=C2NC(Cl)=NC2=CC=C1
MDL No. :MFCD10001473
InChI Key :SYUSWWBZZRCZGH-UHFFFAOYSA-N
Pubchem ID :14933023

Safety of [ 15965-57-8 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Computational Chemistry of [ 15965-57-8 ] Show Less

Physicochemical Properties

Num. heavy atoms 11
Num. arom. heavy atoms 9
Fraction Csp3 0.12
Num. rotatable bonds 0
Num. H-bond acceptors 1.0
Num. H-bond donors 1.0
Molar Refractivity 46.07
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

28.68 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

1.64
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

2.81
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

2.52
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

1.9
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

3.12
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

2.4

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-3.25
Solubility 0.094 mg/ml ; 0.000564 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-3.07
Solubility 0.142 mg/ml ; 0.000852 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-3.91
Solubility 0.0207 mg/ml ; 0.000124 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

Yes
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-5.32 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.49

Application In Synthesis of [ 15965-57-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 15965-57-8 ]

[ 15965-57-8 ] Synthesis Path-Downstream   1~27

  • 1
  • [ 100-44-7 ]
  • [ 15965-57-8 ]
  • 1-benzyl-2-chloro-7-methylbenzimidazole [ No CAS ]
  • 1-benzyl-2-chloro-4-methylbenzimidazole [ No CAS ]
  • 2
  • [ 100-44-7 ]
  • [ 15965-57-8 ]
  • 1-benzyl-2-chloro-4-methylbenzimidazole [ No CAS ]
  • 3
  • [ 532-27-4 ]
  • [ 15965-57-8 ]
  • 2-chloro-4-methyl-1-phenacylbenzimidazole [ No CAS ]
  • 4
  • [ 3587-60-8 ]
  • [ 15965-57-8 ]
  • 1-benzyloxymethyl-2-chloro-4-methylbenzimidazole [ No CAS ]
  • 1-benzyloxymethyl-2-chloro-7-methylbenzimidazole [ No CAS ]
  • 5
  • [ 107-59-5 ]
  • [ 15965-57-8 ]
  • 1-tert-butoxycarbonylmethyl-2-chloro-4-methylbenzimidazole [ No CAS ]
  • 6
  • [ 109-65-9 ]
  • [ 15965-57-8 ]
  • 1-butyl-2-chloro-4-methylbenzimidazole [ No CAS ]
  • 1-butyl-2-chloro-7-methylbenzimidazole [ No CAS ]
  • 7
  • [ 542-69-8 ]
  • [ 15965-57-8 ]
  • 1-butyl-2-chloro-4-methylbenzimidazole [ No CAS ]
  • 1-butyl-2-chloro-7-methylbenzimidazole [ No CAS ]
  • 8
  • [ 109-69-3 ]
  • [ 15965-57-8 ]
  • 1-butyl-2-chloro-4-methylbenzimidazole [ No CAS ]
  • 1-butyl-2-chloro-7-methylbenzimidazole [ No CAS ]
YieldReaction ConditionsOperation in experiment
With trichlorophosphate; at 90℃; for 5h; General procedure: A mixture of 5-methyl-1,3-dihydrobenzimidazol-2-one (2) (24.4 g) and phosphoryl chloride (245 mL) was stirred at 90 C. for 5 hr. After cooling to room temperature, chloroform (250 mL) was added to the reaction mixture. After stirring at room temperature, the resulting precipitate was collected by filtration, and washed 5 times with chloroform (100 mL). To the precipitate was added a mixture of ethyl acetate and saturated sodium hydrogen carbonate solution. After stirring at room temperature, the organic phase was successively washed with water and brine, and dried over magnesium sulfate. The solvent was evaporated under reduced pressure. The residue was powdered with hexane and diisopropyl ether to give 2-chloro-5-methyl-1H-benzimidazole (3) (20.4 g). [0104] ESI-HRMS (positive ion, sodium formate): calcd for C8H8ClN2([M+H]+) 167.0371. found 167.0391 [0105] NMR (DMSO-d6, delta): 2.40 (3H, s), 7.00-7.06 (1H, m), 7.29 (1H, s), 7.39 (1H, d, J=8.2 Hz)
  • 11
  • [ 6974-32-9 ]
  • [ 15965-57-8 ]
  • 2-chloro-4-methyl-1-[β-D-erythro-pentofuranosyl]-1H-benzimidazole [ No CAS ]
  • 12
  • [ 530-62-1 ]
  • [ 2687-25-4 ]
  • [ 15965-57-8 ]
  • 13
  • [ 4330-21-6 ]
  • [ 15965-57-8 ]
  • 2-chloro-1-[2'-deoxy-3',5'-di-O-toluoyl-β-D-ribofuranosyl]-4-methyl-1H-benzimidazole [ No CAS ]
  • 2-chloro-3-[2'-deoxy-3',5'-di-O-toluoyl-β-D-ribofuranosyl]-4-methyl-1H-benzimidazole [ No CAS ]
  • 14
  • [ 4330-21-6 ]
  • [ 15965-57-8 ]
  • 2-chloro-1-[2'-deoxy-β-D-ribofuranosyl]-4-methyl-1H-benzimidazole [ No CAS ]
  • 15
  • [ 19190-68-2 ]
  • [ 15965-57-8 ]
YieldReaction ConditionsOperation in experiment
93% With trichlorophosphate; for 20h;Heating / reflux; 2-Hydroxy-4-methylbenzimidazole (5.92 g, 40 mmol) and 40 ml of phosphoryl chloride are introduced into a 250 ml two-necked flask under an argon atmosphere, equipped with a magnetic stirrer. The mixture is refluxed for 20 hours and the phosphoryl chloride is evaporated off under vacuum. The solid obtained is taken up in water (250 ml), the mixture is neutralized to pH=8 with 28% aqueous ammonia and the aqueous phase is extracted with ethyl acetate (3*250 ml). After the usual work-up, the 2-chloro-4-methylbenzimidazole is obtained in a yield of 93% (6.23 g). 1H NMR (300 MHz, delta ppm) DMSO-d6: 2.47 (s, 3H), 7.01 (d, 1H), 7.11 (t, 1H), 7.32 (d, 1H).
93% (6.23 g) With ammonium hydroxide; trichlorophosphate; In water; 1.4.2. 2-Chloro-4-methylbenzimidazole 2-Hydroxy-4-methylbenzimidazole (5.92 g, 40 mmol) and 40 mL of phosphoryl chloride are introduced into a 250 mL two-necked flask under an argon atmosphere, with magnetic stirring. The mixture is refluxed for 20 hours and the phosphoryl chloride is evaporated off under vacuum. The solid obtained is taken up in water (250 mL), neutralized to pH=8 with 28% aqueous ammonia and the aqueous phase is extracted with ethyl acetate (3*250 mL). After the usual work-up, the title product is obtained in a yield of 93% (6.23 g). 1H NMR (300 MHz, delta ppm) DMSO D6: 2.47 (s, 3H), 7.01 (d, 1H), 7.11 (t, 1H), 7.32 (d, 1H).
  • 16
  • [ 19190-68-2 ]
  • [ 15965-57-8 ]
YieldReaction ConditionsOperation in experiment
62% With trichlorophosphate; at 135℃; for 3h; Step A: 2-Chloro-4-methyl-l -benzo[d]imidazole To 4-methyl-lH-benzo[d]imidazol-2(3H)-one (1.5 g, 10 mmol) was added POCb (19 ml, 200 mmol) and the reaction mixture was heated to 135 C for 3 hours. The reaction was then cooled to room temperature and the excess POCb was removed in vacuo. The solid residue was diluted carefully with water and then slowly neutralized with saturated NaHCC until the pH was ~7-8. The mixture was extracted with ethyl acetate (2 x 150 mL) and the organics extracts were combined. The organics were dried with MgS04, filtered, and the solvent was removed to yield the crude residue. The crude material was purified by chromatography (Biotage) to yield 2-chloro-7-methyl-lH- benzo[d]imidazole (1.1 g, 6.3 mmol, 62 % yield) as a slightly yellow powder. MS (LC/MS) R.T. = 2.61 ; [M+]+ = 166.93
With hydrogenchloride; ammonium hydroxide; In chloroform; water; trichlorophosphate; Part B. 2-Chloro-4-methyl-1H-benzimidazole Hydrogen chloride gas was bubbled through a stirred mixture of 4-methyl-1H-benzimidazolidone (5 g, 0.034 mol) in phosphorus oxychloride (50 mL) for 1 hour at 120 C. The solvent was removed and the resulting solid was dissolved in water (50 mL). Ammonium hydroxide (20 mL) was carefully added until the mixture was basic. The aqueous phase was then extracted with chloroform, filtered through celite, and evaporated to give 5.2 g, of brown oil. The product was chromatographed on silica gel in chloroform, and was eluted with 1% methanol:chloroform to give 3.96 g of brown oil. Crystallization from ethyl acetate:hexane gave 2.72 g of brown crystals, mp 137.5-139.5 C.
With trichlorophosphate; at 95℃; for 1.5h; General procedure: A mixture of 5-methyl-1,3-dihydrobenzimidazol-2-one (1.00 g, 6.84 mmol) and phosphorous oxychloride (9.54 mL, 103 mmol) was stirred for 1.5 h at 95 C. After being cooled to ambient temperature, the reaction mixture was carefully added to a mixture of saturated NaHCO3 aq. (60 mL) and ethyl acetate (60 mL). The separated organic layer was washed with water, brine, and dried over MgSO4. After filtration, the filtrate was evaporated in vacuo, The resulting precipitates were collected by filtration, and successfully washed with isopropyl ether to give 2-chloro-5-methyl-benzimidazole (1.74 g, 58.9 %).
  • 17
  • 3-oxospiro[isobenzofuran-1(3H),4'-piperidine] hydrochloride [ No CAS ]
  • [ 15965-57-8 ]
  • [ 1075752-99-6 ]
  • 18
  • [ 24424-99-5 ]
  • [ 15965-57-8 ]
  • [ 256519-07-0 ]
  • 19
  • [ 15965-57-8 ]
  • [ 1453097-30-7 ]
  • 20
  • [ 15965-57-8 ]
  • [ 1453097-14-7 ]
  • 21
  • [ 15965-57-8 ]
  • [ 63503-83-3 ]
YieldReaction ConditionsOperation in experiment
With hydrazine hydrate; at 100℃; General procedure: A mixture of 2-chloro-5-methyl-benzimidazole (10.2 g, 61.2 mmol) and hydrazine monohydrate (59 mL, 1.22 mol) was stirred at 100 C overnight. After being cooled to ambient temperature, to the reaction mixture was added to water (60 mL). After stirring under ice cooling, the resulting precipitates were collected by filtration. The precipitates were washed with water 3 times, and then dried in vacuo to give 2-hydrazino-5-methyl-benzimidazole (8.4 g, 84.6%).
  • 23
  • [ 15965-57-8 ]
  • (R)-8-methyl-3H-1’-azaspiro[benzo[4,5]imidazo[2,1-b]oxazole-2,3’-bicyclo[2.2.2]octane] [ No CAS ]
  • (S)-8-methyl-3H-1’-azaspiro[benzo[4,5]imidazo[2,1-b]oxazole-2,3’-bicyclo[2.2.2]octane] [ No CAS ]
  • 24
  • [ 160072-43-5 ]
  • [ 15965-57-8 ]
  • (8-methyl-3H-1'-azaspiro[benzo[4,5]imidazo[2,1-b]oxazole-2,3'-bicyclo[2.2.2]octan]-1'-yl-8-ium)trihydroborate [ No CAS ]
YieldReaction ConditionsOperation in experiment
52% Step B: (8-Methyl-3H-l '-azaspiro[benzo[4,5]imidazo[2, l-b]oxazole-2,3 '- bicyclo[2.2.2]octan]-l '-yl-8-ium)trihydroborate To 2-chloro-7-methyl-lH-benzo[d]imidazole (0.65 g, 3.9 mmol) from example 10, step A, in THF (35 mL) was added n-butyllithium (1.6 mL, 3.9 mmol) dropwise at - 78C. After 45 minutes, a solution of racemic (l'-azaspiro[oxirane-2,3'- bicyclo[2.2.2]octan]-l'-yl-4-ium)trihydroborate (0.66 g, 4.29 mmol) from the reference example, in THF (10 mL) was added dropwise at -78C. The cooling bath ws removed and the reaction mixture warmed to room temperature. After 15 minutes, the mixture was heated to 75C for 2 hours and then cooled to room temperature. The reaction was quenched with water and the product was extracted with ethyl acetate (100 mL). The organics were dried with MgS04, filtered and the solvent was removed to yield the crude product. The crude material was purified by chromatography (Biotage) to yield racemic (8-methyl-3H-l'-azaspiro[benzo[4,5]imidazo[2, l-b]oxazole-2,3'-bicyclo[2.2.2]octan]-r- yl-10-ium)trihydroborate (0.40 g, 1.4 mmol, 52%). The 5-methyl regioisomer product was not observed. MS (LC/MS) R.T. = 1.90; [M+1-BH3]+ = 270.07.
52% To 2-chloro-7-methyl-1H-benzo[d]imidazole (0.65 g, 3.9 mmol) from example 10, step A, in THF (35 mL) was added n-butyllithium (1.6 mL, 3.9 mmol) dropwise at -78C. After 45 minutes, a solution of racemic (1'-azaspiro[oxirane-2,3'-bicyclo[2.2.2]octan]-1'-yl-4-ium)trihydroborate (0.66 g, 4.29 mmol) from the reference example, in THF (10 mL) was added dropwise at -78C. The cooling bath ws removed and the reaction mixture warmed to room temperature. After 15 minutes, the mixture was heated to 75C for 2 hours and then cooled to room temperature. The reaction was quenched with water and the product was extracted with ethyl acetate (100 mL). The organics were dried with MgSO4, filtered and the solvent was removed to yield the crude product. The crude material was purified by chromatography (Biotage) to yield racemic (8-methyl-3H-1'-azaspiro[benzo[4,5]imidazo[2,1-b]oxazole-2,3'-bicyclo[2.2.2]octan]-1'-yl-10-ium)trihydroborate (0.40 g, 1.4 mmol, 52%). The 5-methyl regioisomer product was not observed. MS (LC/MS) R.T. = 1.90; [M+1-BH3]+ = 270.07.
  • 25
  • [ 146651-75-4 ]
  • [ 15965-57-8 ]
  • tert-butyl 2-(4-methyl-1H-benzo[d]imidazol-2-ylamino)phenylcarbamate [ No CAS ]
  • 26
  • [ 146651-75-4 ]
  • [ 15965-57-8 ]
  • 1-(4-methyl-1H-benzo[d]imidazol-2-yl)-1H-benzo[d]imidazol-2(3H)-one [ No CAS ]
  • 27
  • [ 160072-43-5 ]
  • [ 15965-57-8 ]
  • (R)-8-methyl-3H-1’-azaspiro[benzo[4,5]imidazo[2,1-b]oxazole-2,3’-bicyclo[2.2.2]octane] [ No CAS ]
  • (S)-8-methyl-3H-1’-azaspiro[benzo[4,5]imidazo[2,1-b]oxazole-2,3’-bicyclo[2.2.2]octane] [ No CAS ]
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 15965-57-8 ]

Chlorides

Chemical Structure| 4857-06-1

A292813 [4857-06-1]

2-Chloro-1H-benzo[d]imidazole

Similarity: 0.89

Chemical Structure| 401567-00-8

A258313 [401567-00-8]

2-Chloro-1H-benzo[d]imidazole-5-carbonitrile

Similarity: 0.78

Chemical Structure| 108662-49-3

A310707 [108662-49-3]

2-Chloro-6-fluoro-1H-benzo[d]imidazole

Similarity: 0.78

Chemical Structure| 16865-11-5

A129006 [16865-11-5]

2,5,6-Trichloro-1H-benzo[d]imidazole

Similarity: 0.75

Chemical Structure| 256518-97-5

A262531 [256518-97-5]

2-Chloro-5-iodo-1H-benzo[d]imidazole

Similarity: 0.75

Related Parent Nucleus of
[ 15965-57-8 ]

Benzimidazoles

Chemical Structure| 4857-06-1

A292813 [4857-06-1]

2-Chloro-1H-benzo[d]imidazole

Similarity: 0.89

Chemical Structure| 4887-83-6

A194340 [4887-83-6]

7-Methyl-1H-benzo[d]imidazole

Similarity: 0.84

Chemical Structure| 614-97-1

A131930 [614-97-1]

5-Methyl-1H-benzo[d]imidazole

Similarity: 0.81

Chemical Structure| 401567-00-8

A258313 [401567-00-8]

2-Chloro-1H-benzo[d]imidazole-5-carbonitrile

Similarity: 0.78

Chemical Structure| 108662-49-3

A310707 [108662-49-3]

2-Chloro-6-fluoro-1H-benzo[d]imidazole

Similarity: 0.78